Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Reliq Health Technologies Inc V.RHT

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a Canada-based global healthcare technology company that specializes in developing virtual care solutions. The Company's target markets include virtual care, long-term care and big data. iUGO Care, the Company's platform, is a software as a service solution that supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, remote therapeutic monitoring and wound care. Its behavioral health integration service supports patients with any mental, behavioral, or psychiatric health diagnoses by integrating mental health, psychiatric care, counseling, and addiction services with primary care.


TSXV:RHT - Post by User

Comment by theinvestor22on Jun 07, 2022 2:47pm
146 Views
Post# 34737885

RE:RE:RE:RE:RE:Lisa chit chat

RE:RE:RE:RE:RE:Lisa chit chatLet's just take stock of where the company is:

- Some said former problem employees would destroy the company.  Not true.  And those former employees paid Reliq compensation.
- Some complained the company wouldn't be able to sign contracts since their troubles.  Not true.  199 contracts according to my count and new ones being added weekly.
- I recall statements that nobody of any size would partner with them.  Not true.  Cognizant, among others have partnered, and Cognizant said on an earnings release conference call that they expect the partnership to improve their bottom line and margins.  That wouldn't be possible without some material developments.
- Some investors complained about the lack of a big four auditor.  The company engaged KPMG, with related due diligence, some time ago.
- Some folks said that the niche was too small to be relevant.  Not true.  The niche has gotten huge.
- Some posters said the company would be overtaken by competition.  Not true.  Not only has Reliq stayed out front, but it has dramatically deepened and expanded its offerings over the years, plus it has increased its average contracted dollar charge per patient per month.
- Some folks said the company's clients would never pay.  Not true.  All of the old receivables are gone.  Yup, there's lots to come, but there's no doubt CMS wants this service and wants to pay.

Now we get a former shareholder claiming Lisa hasn't been a CEO with relevant experience before.  Not true and worthy of pointing out that if you're only looking for companies whose CEOs have sold out for billions, perhaps the Venture Exchange is the wrong place for you.  In other words, you didn't do proper due diligence when you first bought shares in the company, which is on you.  This same individual claims there is no independent director.  Not true unless you define independent as someone you've never heard of before.

Is the company perfect?  Nope.  Is it way better than it was?  Absolutely.  Could I find something imperfect about the vast majority of small companies out there?  Yup, Easy peasy.

It seems to me that we basically have a lot of people claiming the home team isn't a winner yet when they are clearly still in the early innings of the game.

Like I said before, you can focus on what Lisa said or Lisa estimated, but that's not the way to approach this.  Just focus on what the company is doing.  Just to reiterate:

                              Quarterly      Annualized
f 2021 rev:           avg 0.37M          1.46M
f 2022 Q1 rev:          $1.61M          6.44M
f 2022 Q2 rev:          $2.14M          8.56M
f 2022 Q3 rev:          $2.52M        10.08M
 
That's decent progress.  Unless covid becomes a big problem again, I'm thinking calendar H2 should be a much bigger improvement from there.  Blue sky...
<< Previous
Bullboard Posts
Next >>